Oncology Business Management | Specialty

Case Study Presented at IPCC

May 13th 2010

At the Third Annual Interdisciplinary Prostate Cancer Congress in March, the audience viewed presentations of real prostate cancer cases treated by the speakers. How would you treat the patient in this case study? Compare your responses with those of the attendees and the expert panel.

Renowned Prostate Cancer Experts Translate Research into Practice at the IPCC

May 13th 2010

Three presentations at the recent Third Annual Interdisciplinary Prostate Cancer Congress in New York are reviewed. Urologist Leonard Gomella, MD, addresses truths and myths about prostate cancer prevention;Daniel P. Petrylak, MD, discusses the timely topic of immunotherapy; and E. David Crawford, MD, talks about screening controversies.

FDA Updates: May 12, 2010

May 12th 2010

FDA Approval Process Longer for Generics

May 12th 2010

Healthcare professionals and patients are facing a longer wait for the FDA to approve generic drugs than they were just 5 years ago--1 year longer, in fact. The delayed approval process is due to a growing backlog of applications at the FDA.

Ifosfamide Enhances Efficacy of Cisplatin-Etoposide Chemotherapy

May 12th 2010

In data presented at the 2nd European Lung Cancer Conference, a team of investigators said adding ifosfamide to a combination regimen of cisplatin plus etoposide demonstrated strong activity and tolerability in patients with small cell lung cancer (SCLC).

Biomarkers Predict Risk of Recurrence After Lumpectomy for DCIS

May 12th 2010

Being able to predict which women diagnosed with ductal carcinoma in situ (DCIS) are likely to develop subsequent invasive breast cancer could prevent a lot of unnecessary treatment, said researchers from the University of California San Francisco (UCSF).

International Survey Asks Oncologists What They Value in a Pharmaceutical Company

May 12th 2010

Kantar Health Research recently conducted an Internet survey of approximately 250 oncologists from the United States, France, Germany, Italy,Spain, and the United Kingdom. Using a proprietary scoring system Kantar Health calls the TRI*M Index, the research firm assessed relationships between physicians and pharmaceutical company representatives.

ASCO/CAP Issue New Guidelines for IHC Hormone Testing in Breast Cancer

May 12th 2010

The American Society of Clinical Oncology (ASCO)and the College of American Pathologists (CAP) jointly released guidelines designed to improve the accuracy and usefulness of immunohistochemical (IHC) testing for estrogen receptor (ER) and progesterone receptor (PgR) status in breast cancer tumors after convening a panel of international experts to study the issue.

Introducing the Oncology Specialty Group

May 12th 2010

Oncology & Biotech News is now united with the experienced publishing, editorial, and creative staff of Oncology Net Guide and OncLive Nursing under the Oncology Specialty Group umbrella, which also includes our newest publication, Contemporary Oncology.

2010 Conference and Course Calendar

May 6th 2010

June-December Calender

2010 Asco Annual Meeting

May 6th 2010

Notable sessions and events

Oncology Gadget Watch: May 6, 2010

May 6th 2010

Three hot Gadgets

Latest Technologies in Radiation Oncology

May 6th 2010

In a presentation at the Third Annual Interdisciplinary Prostate Cancer Congress (IPCC), Howard M. Sandler, MD, MS, a Ronald H. Bloom Family Chair in Cancer Therapeutics and professor and chair of the Department of Radiation Oncology at Cedars Sinai Medical Center in Los Angeles,

5-FU Dose Optimization: Another Step Towards Personalizing Cancer Care

May 5th 2010

According to the Centers for Disease Control and Prevention, colorectal cancer is the second leading cancer killer in the United States, affecting both men and women.

Collaborative Effort to Address the Needs of Cancer Survivors

May 5th 2010

"In most cancer centers, and in good community practices, we do a pretty good job at the time of diagnosis informing a patient and their family what the diagnosis is, and what they'll need to do to get through treatment," Ganz says. "But patients often have no idea what to expect once they've finished their cancer treatment, and neither do the primary care providers on their t

Online Communication Tool Improves Physician-Patient Communication

May 5th 2010

An Interview with ProCure Treatment Centers' Founder: John Cameron, PhD

May 5th 2010

Proton therapy centers are being built around the country, and one of the companies leading this effort is ProCure, a company dedicated to improving the lives of patients with cancer by increasing access to proton therapy. Since 2005, ProCure has developed several centers and more are underway.

PROTONS: A ray of hope in oncology

May 5th 2010

Radiation therapy has been used to treat cancer for more than 100 years, and was made possible by the discovery of X-rays in 1895 by German physicist Wilhelm Conrad Röntgen, which allowed tumors to be detected more easily and noninvasively.

Ovarian Cancer Screening Focuses on Improving Early Detection

May 5th 2010

The Ovarian Cancer National Alliance states that approximately 20,000 American women receive an ovarian cancer diagnosis annually, with about 15,000 dying of the disease.

E-books: Will they impact education and dissemination of medical information?

April 30th 2010

Electronic communication technologies have radically changed our world, transforming almost every aspect of our daily lives. Most of the tasks we need to perform can be handled electronically, from paying bills and shopping to communicating with friends and family.